RELA and age-related macular degeneration: First, in our study, we searched for several therapeutic targets against subtype B AMD, we found RELA at the transcription factor level, and we found hsa-mir-155-5p at the miRNA level, but we still need to consider robust functional experiments to validate its pathogenic mechanism and therapeutic possibilities as a therapeutic target, and our group will follow up the experimental studies to further explore the pathogenesis of AMD and therapeutic targets.